Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Nov;38(5):606–611. doi: 10.1038/bjc.1978.256

E-rosette-forming cells at 29 degrees C: an assay for the evaluation of the immune status of cancer patients.

P C Quan, P Burtin
PMCID: PMC2009783  PMID: 310311

Abstract

High-affinity rosette-forming T-cell assays were performed by incubation of peripheral-blood mononuclear cells with sheep erythrocytes (E) at 29 degrees C. As compared with normal controls, the levels of high-affinity rosette-forming cells (RFC) were much more frequently depressed in cancer patients than were the total E-RFC incubated at 4 degrees C. Only 2/83 normal controls had less than 38% 29 degrees C E-RFC (mean 48 +/- 5), whilst 78/89 cancer patients were below this level. The few postoperative patients tested exhibited a normal range of 29 degrees C E-RFC. The 29 degrees C E-rosette assay gives reproducible counts of a T-cell subset, and is a sensitive assay for evaluating the immune status of cancer patients.

Full text

PDF
606

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berlinger N. T., Lopez C., Good R. A. Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells. Nature. 1976 Mar 11;260(5547):145–146. doi: 10.1038/260145a0. [DOI] [PubMed] [Google Scholar]
  2. Catalona W. J., Potvin C., Chretien P. B. T lymphocytes in bladder and prostatic cancer patients. J Urol. 1974 Sep;112(3):378–382. doi: 10.1016/s0022-5347(17)59735-9. [DOI] [PubMed] [Google Scholar]
  3. Chisholm R. L., Tubergen D. G. The significance of varying SRBC/lymphocyte ratio in T cell rosette formation. J Immunol. 1976 May;116(5):1397–1399. [PubMed] [Google Scholar]
  4. Jerrells T. R., Dean J. H., Herberman R. B. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients. Int J Cancer. 1978 Mar 15;21(3):282–290. doi: 10.1002/ijc.2910210306. [DOI] [PubMed] [Google Scholar]
  5. Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
  6. Keller S. E., Ioachim H. L., Pearse T., Siletti D. M. Decreased T-lymphocytes in patients with mammary cancer. Am J Clin Pathol. 1976 Apr;65(4):445–449. doi: 10.1093/ajcp/65.4.445. [DOI] [PubMed] [Google Scholar]
  7. Nemoto T., Han T., Minowada J., Angkur V., Chamberlain A., Dao L. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells. J Natl Cancer Inst. 1974 Sep;53(3):641–645. doi: 10.1093/jnci/53.3.641. [DOI] [PubMed] [Google Scholar]
  8. New formulation of digoxin. Lancet. 1972 Oct 28;2(7783):922–923. [PubMed] [Google Scholar]
  9. Perrett A. D., Truelove S. C., Massarella G. R. Crohn's disease and carcinoma of colon. Br Med J. 1968 May 25;2(5603):466–468. doi: 10.1136/bmj.2.5603.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Quan P. C., Burtin P. Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients. Cancer Res. 1978 Feb;38(2):288–296. [PubMed] [Google Scholar]
  11. Smith R., Kerman R., Ezdinli E., Stefani S. A modified assay for the detection of human adult active rosette forming lymphocytes. J Immunol Methods. 1975;8(1-2):175–184. doi: 10.1016/0022-1759(75)90094-0. [DOI] [PubMed] [Google Scholar]
  12. Weedon D. D., Shorter R. G., Ilstrup D. M., Huizenga K. A., Taylor W. F. Crohn's disease and cancer. N Engl J Med. 1973 Nov 22;289(21):1099–1103. doi: 10.1056/NEJM197311222892101. [DOI] [PubMed] [Google Scholar]
  13. West W. H., Boozer R. B., Herberman R. B. Low affinity E-rosette formation by the human K cell. J Immunol. 1978 Jan;120(1):90–95. [PubMed] [Google Scholar]
  14. West W. H., Payne S. M., Weese J. L., Herberman R. B. Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor. J Immunol. 1977 Aug;119(2):548–554. [PubMed] [Google Scholar]
  15. West W. H., Sienknecht C. W., Townes A. S., Herberman R. B. Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol. 1976 Jan;5(1):60–66. doi: 10.1016/0090-1229(76)90149-5. [DOI] [PubMed] [Google Scholar]
  16. Whitehead R. H., Roberts G. P., Hughes L. E., Thatcher J. Importance of methodology in demonstrating depression of T-lymphocyte levels. Br J Cancer. 1978 Jan;37(1):28–32. doi: 10.1038/bjc.1978.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Whitehead R. H., Thatcher J., Teasdale C., Roberts G. P., Hughes L. E. T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro. Lancet. 1976 Feb 14;1(7955):330–333. doi: 10.1016/s0140-6736(76)90085-4. [DOI] [PubMed] [Google Scholar]
  18. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES